At the upper end of the price band, the Molbio Diagnostics IPO is valued at ₹930.7 crore. The issue comprises a fresh issue of shares worth ₹200 crore and an offer for sale (OFS) of 91.66 lakh shares by existing shareholders.
At the upper end of the price band, the Molbio Diagnostics IPO is valued at ₹930.7 crore. The issue comprises a fresh issue of shares worth ₹200 crore and an offer for sale (OFS) of 91.66 lakh shares by existing shareholders.